Formulations utilizing high-potent APIs is one of the Gen-Plus key competencies. Over 60 drug products of cytostatics, immunosuppressives and kinase inhibitors (OEB 4-5) were developed for customers so far. Recently the company accomplished the manufacturing permit for high-potent Clinical Trial Supplies. Please consider us as your high potent center of excellence!

Related Posts

  • Science Day 2023

    read more

  • Handing over the baton at Gen-Plus

    read more

  • From Houston to Munich – Innovation & Compounding

    read more